Search research articles
Contact Us
Filters
Showing results (311-320 of 351) with videos related to
Page
of 36
Sort By:
British Journal of Cancer
|
March 23, 2018
A multicentre, open-label, phase-I/randomised phase-II study to evaluate safety, pharmacokinetics, and efficacy of nintedanib vs. sorafenib in European patients with advanced hepatocellular carcinoma
D H Palmer, Y T Ma, M Peck-Radosavljevic, et al.
International Journal of Cancer
|
March 29, 2001
Characterization of (123)I-vascular endothelial growth factor-binding sites expressed on human tumour cells: possible implication for tumour scintigraphy
S Li, M Peck-Radosavljevic, E Koller, et al.
Alimentary Pharmacology & Therapeutics
|
June 30, 2018
Impact of patatin-like phospholipase domain containing 3 rs738409 G/G genotype on hepatic decompensation and mortality in patients with portal hypertension
M Mandorfer, B Scheiner, A F Stättermayer, et al.
Prehospital Emergency Care
|
June 11, 2019
Association Between Intravenous Fluid Bolus and Biomarker Trajectory During Prehospital Care
Emily B Brant, Jason Kennedy, Christian Martin-Gill, et al.
Cancer Research
|
May 15, 1998
Somatostatin receptor subtype specificity and in vivo binding of a novel tumor tracer, 99mTc-P829
I Virgolini, M Leimer, H Handmaker, et al.
European Journal of Nuclear Medicine
|
October 1, 1996
In vitro and in vivo studies of three radiolabelled somatostatin analogues: 123I-octreotide (OCT), 123I-Tyr-3-OCT and 111In-DTPA-D-Phe-1-OCT
I Virgolini, P Angelberger, S Li, et al.
Blood
|
January 29, 2000
Thrombopoietin induces rapid resolution of thrombocytopenia after orthotopic liver transplantation through increased platelet production
M Peck-Radosavljevic, M Wichlas, J Zacherl, et al.
Alimentary Pharmacology & Therapeutics
|
December 3, 2016
Interferon-free regimens improve portal hypertension and histological necroinflammation in HIV/HCV patients with advanced liver disease
P Schwabl, M Mandorfer, S Steiner, et al.
Medical Care
|
February 15, 2001
Measuring patient expectations: does the instrument affect satisfaction or expectations?
B M Peck, D A Asch, S D Goold, et al.
Endocrinology
|
October 28, 1999
DOTA-lanreotide: a novel somatostatin analog for tumor diagnosis and therapy
P M Smith-Jones, C Bischof, M Leimer, et al.
Page
of 36
Search research articles
Search
Showing results (311-320 of 351) with videos related to
Sort By:
Page
of 36
British Journal of Cancer
|
March 23, 2018
A multicentre, open-label, phase-I/randomised phase-II study to evaluate safety, pharmacokinetics, and efficacy of nintedanib vs. sorafenib in European patients with advanced hepatocellular carcinoma
D H Palmer, Y T Ma, M Peck-Radosavljevic, et al.
International Journal of Cancer
|
March 29, 2001
Characterization of (123)I-vascular endothelial growth factor-binding sites expressed on human tumour cells: possible implication for tumour scintigraphy
S Li, M Peck-Radosavljevic, E Koller, et al.
Alimentary Pharmacology & Therapeutics
|
June 30, 2018
Impact of patatin-like phospholipase domain containing 3 rs738409 G/G genotype on hepatic decompensation and mortality in patients with portal hypertension
M Mandorfer, B Scheiner, A F Stättermayer, et al.
Prehospital Emergency Care
|
June 11, 2019
Association Between Intravenous Fluid Bolus and Biomarker Trajectory During Prehospital Care
Emily B Brant, Jason Kennedy, Christian Martin-Gill, et al.
Cancer Research
|
May 15, 1998
Somatostatin receptor subtype specificity and in vivo binding of a novel tumor tracer, 99mTc-P829
I Virgolini, M Leimer, H Handmaker, et al.
European Journal of Nuclear Medicine
|
October 1, 1996
In vitro and in vivo studies of three radiolabelled somatostatin analogues: 123I-octreotide (OCT), 123I-Tyr-3-OCT and 111In-DTPA-D-Phe-1-OCT
I Virgolini, P Angelberger, S Li, et al.
Blood
|
January 29, 2000
Thrombopoietin induces rapid resolution of thrombocytopenia after orthotopic liver transplantation through increased platelet production
M Peck-Radosavljevic, M Wichlas, J Zacherl, et al.
Alimentary Pharmacology & Therapeutics
|
December 3, 2016
Interferon-free regimens improve portal hypertension and histological necroinflammation in HIV/HCV patients with advanced liver disease
P Schwabl, M Mandorfer, S Steiner, et al.
Medical Care
|
February 15, 2001
Measuring patient expectations: does the instrument affect satisfaction or expectations?
B M Peck, D A Asch, S D Goold, et al.
Endocrinology
|
October 28, 1999
DOTA-lanreotide: a novel somatostatin analog for tumor diagnosis and therapy
P M Smith-Jones, C Bischof, M Leimer, et al.
Page
of 36